P
ProHub
English 简体中文 繁體中文
Medium Market Entry Market Sizing Profitability

Botox

#Healthcare
ProHub Comment

This case tests market sizing rigor combined with strategic business considerations. The candidate must calculate a $4.32B addressable market for Botox in migraines while recognizing that executing this launch strategy poses substantial risks around brand cannibalization and regulatory complexity that could outweigh the financial opportunity.

Estimated Time 26 minutes
Difficulty Medium
Source NYU
10 / 100
The maker of Botox is considering expanding to the migraine market and has already begun clinical trials in this area. The product is expected to receive FDA approval in 2019. Your team has been hired to assess the viability of this product for launch. How will you determine if the market is attractive? If the market is attractive, do you have any recommendations regarding how to launch the product? What concerns should the client take into consideration before deciding to launch?

Clarifying Information

  1. Price: The drug will be priced at $200/injection
  2. Cost: Remaining development and launch costs amount to approximately $5B
  3. Manufacturing marginal costs are expected to be quite small
  4. Annual marketing expense can be estimated at $1B
  5. Attributes: The product is a prophylactic injection given every 2 months
  6. Offers similar efficacy compared to market leading option but without any side effects
  7. When taken for migraines it does have some added skin care benefits
  8. Competition: The market leading branded prescription oral migraine treatment lost patent protection last year
  9. Strong over-the-counter generic market for migraine treatments
Mock Interview
Interviewer

The maker of Botox is considering expanding to the migraine market and has already begun clinical trials in this area. The product is expected to receive FDA approval in 2019. Your team has been hired to assess the viability of this product for launch. How will you determine if the market is attractive? If the market is attractive, do you have any recommendations regarding how to launch the product? What concerns should the client take into consideration before deciding to launch?

You

Thanks. Before analyzing, I'd like to clarify a few key questions...

Interviewer

Good question. Let me provide some background information...

You

Based on this, I suggest analyzing from these dimensions...

AI Score
Structure Analysis Communication Business Sense Quantitative
Practicing...
Score coming soon
Practice this case with AI Mock Interview

Assess whether Botox should enter the migraine market by sizing the market opportunity, evaluating launch strategy, and identifying key risks including brand cannibalization, regulatory approval contingencies, and competitive dynamics.

Key Insights:

  1. Market sizing requires structured top-down approach: US population (320M) × chronic migraine prevalence (15%) × severe cases (25%) × price ($200 × 6 injections) = $14.4B total market; Botox captures ~30% = $4.32B opportunity
  2. Brand cannibalization risk is critical: launching Botox migraine at lower price point than cosmetic Botox could drive off-label usage and erode the highly profitable cosmetic segment
  3. Regulatory and patient barriers matter: FDA may require separate labeling/marketing, insurance coverage is uncertain with only comparable efficacy, and patients prefer oral to injectable treatments
  4. Brand strategy is pivotal: launching under different brand name enables market separation, differentiated pricing, and reduced reputational risk if adverse events emerge